Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

Paramount Resources aims to boost oil production to 100,000 BOED by 2027 amid strong management and market conditions

Market News
13 May 2026
Seeking Alpha
View Source
Bullish
pluang ai news

Paramount Resources Ltd. is focusing on increasing its oil production to 100,000 barrels of oil equivalent per day (BOED) by the end of fiscal 2027. The company benefits from strong management expertise that effectively builds and monetizes production assets. Despite planned negative cash flow due to heavy capital investment, rising liquid prices and favorable commodity market conditions driven by geopolitical tensions may offset these costs. Quarterly earnings are less emphasized as the company undergoes rapid transformation, with confidence rooted in management's proven track record.

More News

Life360 launches $225M multi-year share buyback to offset stock dilution

Life360 launches $225M multi-year share buyback to offset stock dilution

Life360's Board of Directors has approved a multi-year share repurchase program worth up to $225 million to reduce dilution from stock-based compensation. The program aims to return value to shareholders and is supported by the company's strong balan...

Company Fundamentals
Bullish
1 hour ago
US-China deal commits China to buy $17B in US farm goods annually through 2028

US-China deal commits China to buy $17B in US farm goods annually through 2028

President Donald Trump secured a major deal with China, where China agreed to purchase at least $17 billion worth of US agricultural products annually until 2028. This agreement was announced after a two-day summit in China, the first by a US preside...

Market News
Bullish
1 hour ago
Trump warns Iran to act fast or face severe consequences amid stalled peace talks.

Trump warns Iran to act fast or face severe consequences amid stalled peace talks.

Former President Donald Trump issued a stern warning to Iran, urging swift action in stalled peace negotiations or face severe consequences. He rejected Iran's demand to separate nuclear talks from peace discussions, emphasizing that time is critical...

Market News
Bearish
2 hours ago
Design Therapeutics to present Phase 1/2 trial data for Friedreich’s ataxia drug DT-216P2 on May 18

Design Therapeutics to present Phase 1/2 trial data for Friedreich’s ataxia drug DT-216P2 on May 18

Design Therapeutics, a clinical-stage biotech company, will announce data from its ongoing Phase 1/2 RESTORE-FA trial of DT-216P2, a treatment for Friedreich’s ataxia, on May 18, 2026. The company will host a live webcast and conference call to discu...

Company Fundamentals
Bullish
2 hours ago
Pluvicto plus standard care cuts PSA progression risk by 58% in metastatic hormone-sensitive prostate cancer.

Pluvicto plus standard care cuts PSA progression risk by 58% in metastatic hormone-sensitive prostate cancer.

Novartis announced that combining Pluvicto (lutetium-177 vipivotide tetraxetan) with standard care (ARPI + ADT) significantly improves PSA response in metastatic hormone-sensitive prostate cancer (mHSPC), reducing PSA progression risk by 58% compared...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App